Cambridge Investment Research Advisors, Inc. Gsk PLC Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$42.05 - $47.77 $965,257 - $1.1 Million	22,955 Added 20.13%	136,978 $6.08 Million
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $17,741 - $21,053	441 Added 0.39%	114,023 $5.06 Million
Q4 2021 Feb 03, 2022	BUY	$38.88 - $45.31 $147,121 - $171,453	3,784 Added 3.45%	113,582 $5.11 Million
Q3 2021 Nov 02, 2021	BUY	$38.79 - $43.16 $56,361 - $62,711	1,453 Added 1.34%	109,798 $4.28 Million
Q2 2021 Aug 10, 2021	BUY	$36.52 - $41.46 $298,441 - $338,811	8,172 Added 8.16%	108,345 $4.4 Million
Q1 2021 May 07, 2021	BUY	$34.27 - $40.01 $35,058 - $40,930	1,023 Added 1.03%	100,173 $3.65 Million
Q4 2020 Feb 04, 2021	SELL	$34.07 - $39.94 $202,307 - $237,163	-5,938 Reduced 5.65%	99,150 $3.72 Million
Q3 2020 Oct 29, 2020	SELL	$38.11 - $42.99 $291,350 - $328,658	-7,645 Reduced 6.78%	105,088 $4.03 Million
Q2 2020 Jul 27, 2020	BUY	$37.87 - $43.58 $528,778 - $608,507	13,963 Added 14.14%	112,733 $4.69 Million
Q1 2020 May 08, 2020	SELL	$32.47 - $48.83 $200,632 - $301,720	-6,179 Reduced 5.89%	98,770 $3.82 Million
Q4 2019 Feb 04, 2020	BUY	$42.0 - $48.25 $141,582 - $162,650	3,371 Added 3.32%	104,949 $5.03 Million
Q3 2019 Nov 06, 2019	SELL	$40.46 - $43.52 $44,951 - $48,350	-1,111 Reduced 1.08%	101,578 $4.42 Million
Q3 2019 Oct 28, 2019	SELL	$40.46 - $43.52 $57,372 - $61,711	-1,418 Reduced 1.36%	102,689 $4.47 Million
Q2 2019 Aug 15, 2019	SELL	$39.4 - $42.7 $501,049 - $543,015	-12,717 Reduced 10.89%	104,107 $0
Q1 2019 May 08, 2019	BUY	$38.57 - $42.69 $210,707 - $233,215	5,463 Added 4.91%	116,824 $0
Q4 2018 Feb 05, 2019	SELL	$37.8 - $42.69 $93,177 - $105,230	-2,465 Reduced 2.17%	111,361 $4.34 Million
Q3 2018 Nov 02, 2018	SELL	$39.75 - $42.69 $123,145 - $132,253	-3,098 Reduced 2.65%	113,826 $0
Q2 2018 Aug 10, 2018	SELL	$39.61 - $42.76 $97,480 - $105,232	-2,461 Reduced 2.06%	116,924 $0
Q1 2018 May 09, 2018	BUY	$36.18 - $40.15 $416,504 - $462,206	11,512 Added 10.67%	119,385 $0
Q4 2017 Feb 22, 2018	BUY	$35.34 - $41.9 $197,267 - $233,885	5,582 Added 5.46%	107,873 $0
Q3 2017 Nov 07, 2017	SELL	$39.44 - $41.55 $375,232 - $395,306	-9,514 Reduced 8.51%	102,291 $4.15 Million
Q2 2017 Aug 08, 2017	BUY	N/A	111,805	111,805 $4.82 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account